H. Chris Segar

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Chandra R. Tate, Lyndsay V. Rhodes, H. Chris Segar et al. · Breast Cancer Research · 2012 · 263 citations · Full text

Medicine, Oncology, Pharmacology +15

Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells

Syreeta L. Tilghman, Melyssa R. Bratton, H. Chris Segar et al. · PLoS ONE · 2012 · 150 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

Lyndsay V. Rhodes, Elizabeth C. Martin, H. Chris Segar et al. · Oncotarget · 2015 · 120 citations · Full text

Medicine, Molecular Biology, Oncology +17

Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators

Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar et al. · Breast Cancer Research and Treatment · 2014 · 102 citations · Full text

Medicine, Cancer Biology, Oncology +16

The Organochlorine <i>o,p’</i> -DDT Plays a Role in Coactivator-Mediated MAPK Crosstalk in MCF-7 Breast Cancer Cells

Melyssa R. Bratton, Daniel E. Frigo, H. Chris Segar et al. · Environmental Health Perspectives · 2012 · 41 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17